Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma
Status:
Terminated
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This is a single arm open- label phase II- trial evaluating safety and efficacy of paclitaxel
and RAD001 in patients with metastatic urothelial bladder cancer who failed prior
platin-based systemic therapy.